Enabling Efficient Oral and Injectable Solubility Enhancement with Apinovex™ and Apisolex™ Polymers

26 September 2022 15:40 - 16:10

  • Review of solubility-enhancement techniques
  • Introduction to Lubrizol’s patented solubility enhancing excipients: oral-grade Apinovex™ polymers and injectable-grade Apisolex™ polymers
  • Formulation and processing benefits of Apinovex and Apisolex
  • Case study data demonstrating solubility enhancement and high drug loading for several APIs
  • Competitive advantages compared to established excipients and techniques

Nick DiFranco, Global Market Segment Manager, Oral Treatments, Lubrizol Life Science Health

Joey Glassco, Global Market Segment Manager, Parenteral Drug Delivery, Lubrizol Life Science Health